APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mammalian Biopharmaceutical Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mammalian Biopharmaceutical Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

12 August 2026199 pages

Choose your research edition.

Industry ResearchMammalian Biopharmaceutical Service Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Mammalian Biopharmaceutical Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Mammalian Biopharmaceutical Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mammalian Biopharmaceutical Service Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Mammalian Biopharmaceutical Service Market Analysis and Forecast 2026-2032184 pages · $4,950 USD

Market perspective

The global Mammalian Biopharmaceutical Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Mammalian Biopharmaceutical Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mammalian Biopharmaceutical Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mammalian Biopharmaceutical Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mammalian Biopharmaceutical Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mammalian Biopharmaceutical Service include Novartis, KBI Biopharma, 3P Biopharmaceuticals, Sartorius Stedim Biotech, Merck Millipore, Rentschler Biopharma SE, Northway Biotech, Cambrex and Samsung Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Mammalian Biopharmaceutical Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mammalian Biopharmaceutical Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mammalian Biopharmaceutical Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Mammalian Biopharmaceutical Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Mammalian Biopharmaceutical Service Segment by Company

Novartis

KBI Biopharma

3P Biopharmaceuticals

Sartorius Stedim Biotech

Merck Millipore

Rentschler Biopharma SE

Northway Biotech

Cambrex

Samsung Biologics

FUJIFILM Diosynth Biotechnologies

GBI

Thermo Fisher Scientific

Catalent

WuXi Biologics

Boehringer Ingelheim BioXcellence

Lonza

Abzena

AGC Biologics

Mammalian Biopharmaceutical Service Segment by Type

Cell Line Development

Analytical Testing

Technology Transfer

Formulation Development

Others

Mammalian Biopharmaceutical Service Segment by Application

Pharmaceutical

Contract Research Organizations (CROs)

Academic and Research Institutes

Biotechnology Companies

Government Agencies

Mammalian Biopharmaceutical Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mammalian Biopharmaceutical Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mammalian Biopharmaceutical Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mammalian Biopharmaceutical Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Mammalian Biopharmaceutical Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mammalian Biopharmaceutical Service industry.

Chapter 3: Detailed analysis of Mammalian Biopharmaceutical Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mammalian Biopharmaceutical Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mammalian Biopharmaceutical Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Cell Line Development Table 3. Key Players of Analytical Testing Table 4. Key Players of Technology Transfer Table 3. Key Players of Formulation Development Table 4. Key Players of Others Table 5. Global Mammalian Biopharmaceutical Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Pharmaceutical Table 7. Key Players of Contract Research Organizations (CROs) Table 8. Key Players of Academic and Research Institutes Table 9. Key Players of Biotechnology Companies Table 10. Key Players of Government Agencies Table 11. Global Mammalian Biopharmaceutical Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Mammalian Biopharmaceutical Service Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Mammalian Biopharmaceutical Service Market Share by Region (2021-2026) Table 14. Global Mammalian Biopharmaceutical Service Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Mammalian Biopharmaceutical Service Market Share by Region (2027-2032) Table 16. Mammalian Biopharmaceutical Service Industry Trends Table 17. Mammalian Biopharmaceutical Service Industry Drivers Table 18. Mammalian Biopharmaceutical Service Industry Opportunities and Challenges Table 19. Mammalian Biopharmaceutical Service Industry Restraints Table 20. Global Mammalian Biopharmaceutical Service Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Mammalian Biopharmaceutical Service Revenue Market Share by Company (2021-2026) Table 22. Global Mammalian Biopharmaceutical Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Mammalian Biopharmaceutical Service Key Company Head Office and Area Served Table 24. Global Mammalian Biopharmaceutical Service Company, Product Type & Application Table 25. Global Mammalian Biopharmaceutical Service Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Mammalian Biopharmaceutical Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Mammalian Biopharmaceutical Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Mammalian Biopharmaceutical Service Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Mammalian Biopharmaceutical Service Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Mammalian Biopharmaceutical Service Revenue Market Share by Type (2021-2026) Table 32. Global Mammalian Biopharmaceutical Service Revenue Market Share by Type (2027-2032) Table 33. Global Mammalian Biopharmaceutical Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Mammalian Biopharmaceutical Service Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Mammalian Biopharmaceutical Service Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Mammalian Biopharmaceutical Service Revenue Market Share by Application (2021-2026) Table 37. Global Mammalian Biopharmaceutical Service Revenue Market Share by Application (2027-2032) Table 38. Novartis Company Information Table 39. Novartis Business Overview Table 40. Novartis Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Novartis Mammalian Biopharmaceutical Service Product Portfolio Table 42. Novartis Recent Development Table 43. KBI Biopharma Company Information Table 44. KBI Biopharma Business Overview Table 45. KBI Biopharma Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. KBI Biopharma Mammalian Biopharmaceutical Service Product Portfolio Table 47. KBI Biopharma Recent Development Table 48. 3P Biopharmaceuticals Company Information Table 49. 3P Biopharmaceuticals Business Overview Table 50. 3P Biopharmaceuticals Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. 3P Biopharmaceuticals Mammalian Biopharmaceutical Service Product Portfolio Table 52. 3P Biopharmaceuticals Recent Development Table 53. Sartorius Stedim Biotech Company Information Table 54. Sartorius Stedim Biotech Business Overview Table 55. Sartorius Stedim Biotech Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Sartorius Stedim Biotech Mammalian Biopharmaceutical Service Product Portfolio Table 57. Sartorius Stedim Biotech Recent Development Table 58. Merck Millipore Company Information Table 59. Merck Millipore Business Overview Table 60. Merck Millipore Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Merck Millipore Mammalian Biopharmaceutical Service Product Portfolio Table 62. Merck Millipore Recent Development Table 63. Rentschler Biopharma SE Company Information Table 64. Rentschler Biopharma SE Business Overview Table 65. Rentschler Biopharma SE Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Rentschler Biopharma SE Mammalian Biopharmaceutical Service Product Portfolio Table 67. Rentschler Biopharma SE Recent Development Table 68. Northway Biotech Company Information Table 69. Northway Biotech Business Overview Table 70. Northway Biotech Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Northway Biotech Mammalian Biopharmaceutical Service Product Portfolio Table 72. Northway Biotech Recent Development Table 73. Cambrex Company Information Table 74. Cambrex Business Overview Table 75. Cambrex Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Cambrex Mammalian Biopharmaceutical Service Product Portfolio Table 77. Cambrex Recent Development Table 78. Samsung Biologics Company Information Table 79. Samsung Biologics Business Overview Table 80. Samsung Biologics Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Samsung Biologics Mammalian Biopharmaceutical Service Product Portfolio Table 82. Samsung Biologics Recent Development Table 83. FUJIFILM Diosynth Biotechnologies Company Information Table 84. FUJIFILM Diosynth Biotechnologies Business Overview Table 85. FUJIFILM Diosynth Biotechnologies Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. FUJIFILM Diosynth Biotechnologies Mammalian Biopharmaceutical Service Product Portfolio Table 87. FUJIFILM Diosynth Biotechnologies Recent Development Table 88. GBI Company Information Table 89. GBI Business Overview Table 90. GBI Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. GBI Mammalian Biopharmaceutical Service Product Portfolio Table 92. GBI Recent Development Table 93. Thermo Fisher Scientific Company Information Table 94. Thermo Fisher Scientific Business Overview Table 95. Thermo Fisher Scientific Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 96. Thermo Fisher Scientific Mammalian Biopharmaceutical Service Product Portfolio Table 97. Thermo Fisher Scientific Recent Development Table 98. Catalent Company Information Table 99. Catalent Business Overview Table 100. Catalent Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 101. Catalent Mammalian Biopharmaceutical Service Product Portfolio Table 102. Catalent Recent Development Table 103. WuXi Biologics Company Information Table 104. WuXi Biologics Business Overview Table 105. WuXi Biologics Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 106. WuXi Biologics Mammalian Biopharmaceutical Service Product Portfolio Table 107. WuXi Biologics Recent Development Table 108. Boehringer Ingelheim BioXcellence Company Information Table 109. Boehringer Ingelheim BioXcellence Business Overview Table 110. Boehringer Ingelheim BioXcellence Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 111. Boehringer Ingelheim BioXcellence Mammalian Biopharmaceutical Service Product Portfolio Table 112. Boehringer Ingelheim BioXcellence Recent Development Table 113. Lonza Company Information Table 114. Lonza Business Overview Table 115. Lonza Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 116. Lonza Mammalian Biopharmaceutical Service Product Portfolio Table 117. Lonza Recent Development Table 118. Abzena Company Information Table 119. Abzena Business Overview Table 120. Abzena Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 121. Abzena Mammalian Biopharmaceutical Service Product Portfolio Table 122. Abzena Recent Development Table 123. AGC Biologics Company Information Table 124. AGC Biologics Business Overview Table 125. AGC Biologics Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 126. AGC Biologics Mammalian Biopharmaceutical Service Product Portfolio Table 127. AGC Biologics Recent Development Table 128. North America Mammalian Biopharmaceutical Service Market Size by Type (2021-2026) & (US$ Million) Table 129. North America Mammalian Biopharmaceutical Service Market Size by Type (2027-2032) & (US$ Million) Table 130. North America Mammalian Biopharmaceutical Service Market Size by Application (2021-2026) & (US$ Million) Table 131. North America Mammalian Biopharmaceutical Service Market Size by Application (2027-2032) & (US$ Million) Table 132. North America Mammalian Biopharmaceutical Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. North America Mammalian Biopharmaceutical Service Market Size by Country (2021-2026) Table 134. North America Mammalian Biopharmaceutical Service Market Size by Country (2027-2032) Table 135. Europe Mammalian Biopharmaceutical Service Market Size by Type (2021-2026) & (US$ Million) Table 136. Europe Mammalian Biopharmaceutical Service Market Size by Type (2027-2032) & (US$ Million) Table 137. Europe Mammalian Biopharmaceutical Service Market Size by Application (2021-2026) & (US$ Million) Table 138. Europe Mammalian Biopharmaceutical Service Market Size by Application (2027-2032) & (US$ Million) Table 139. Europe Mammalian Biopharmaceutical Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Mammalian Biopharmaceutical Service Market Size by Country (2021-2026) Table 141. Europe Mammalian Biopharmaceutical Service Market Size by Country (2027-2032) Table 142. China Mammalian Biopharmaceutical Service Market Size by Type (2021-2026) & (US$ Million) Table 143. China Mammalian Biopharmaceutical Service Market Size by Type (2027-2032) & (US$ Million) Table 144. China Mammalian Biopharmaceutical Service Market Size by Application (2021-2026) & (US$ Million) Table 145. China Mammalian Biopharmaceutical Service Market Size by Application (2027-2032) & (US$ Million) Table 146. Asia Mammalian Biopharmaceutical Service Market Size by Type (2021-2026) & (US$ Million) Table 147. Asia Mammalian Biopharmaceutical Service Market Size by Type (2027-2032) & (US$ Million) Table 148. Asia Mammalian Biopharmaceutical Service Market Size by Application (2021-2026) & (US$ Million) Table 149. Asia Mammalian Biopharmaceutical Service Market Size by Application (2027-2032) & (US$ Million) Table 150. Asia Mammalian Biopharmaceutical Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Asia Mammalian Biopharmaceutical Service Market Size by Country (2021-2026) Table 152. Asia Mammalian Biopharmaceutical Service Market Size by Country (2027-2032) Table 153. South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Type (2021-2026) & (US$ Million) Table 154. South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Type (2027-2032) & (US$ Million) Table 155. South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Application (2021-2026) & (US$ Million) Table 156. South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Application (2027-2032) & (US$ Million) Table 157. South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country (2021-2026) Table 159. South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country (2027-2032) Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Mammalian Biopharmaceutical Service Product Image Figure 2. Global Mammalian Biopharmaceutical Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Mammalian Biopharmaceutical Service Market Share by Type: 2025 VS 2032 Figure 4. Cell Line Development Image Figure 5. Analytical Testing Image Figure 6. Technology Transfer Image Figure 7. Formulation Development Image Figure 8. Others Image Figure 9. Global Mammalian Biopharmaceutical Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Mammalian Biopharmaceutical Service Market Share by Application: 2025 VS 2032 Figure 11. Pharmaceutical Image Figure 12. Contract Research Organizations (CROs) Image Figure 13. Academic and Research Institutes Image Figure 14. Biotechnology Companies Image Figure 15. Government Agencies Image Figure 16. Global Mammalian Biopharmaceutical Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 18. Global Mammalian Biopharmaceutical Service Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Mammalian Biopharmaceutical Service Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Mammalian Biopharmaceutical Service Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Mammalian Biopharmaceutical Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Mammalian Biopharmaceutical Service Revenue Market Share by Type (2021-2032) Figure 25. Global Mammalian Biopharmaceutical Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Mammalian Biopharmaceutical Service Revenue Market Share by Application (2021-2032) Figure 27. North America Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 28. North America Mammalian Biopharmaceutical Service Market Share by Type (2021-2032) Figure 29. North America Mammalian Biopharmaceutical Service Market Share by Application (2021-2032) Figure 30. North America Mammalian Biopharmaceutical Service Market Share by Country (2021-2032) Figure 31. United States Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 32. Canada Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 34. Europe Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 35. Europe Mammalian Biopharmaceutical Service Market Share by Type (2021-2032) Figure 36. Europe Mammalian Biopharmaceutical Service Market Share by Application (2021-2032) Figure 37. Europe Mammalian Biopharmaceutical Service Market Share by Country (2021-2032) Figure 38. Germany Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 39. France Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 41. Italy Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 42. Russia Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 44. China Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 45. China Mammalian Biopharmaceutical Service Market Share by Type (2021-2032) Figure 46. China Mammalian Biopharmaceutical Service Market Share by Application (2021-2032) Figure 47. Asia Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 48. Asia Mammalian Biopharmaceutical Service Market Share by Type (2021-2032) Figure 49. Asia Mammalian Biopharmaceutical Service Market Share by Application (2021-2032) Figure 50. Asia Mammalian Biopharmaceutical Service Market Share by Country (2021-2032) Figure 51. Japan Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 55. India Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 56. Australia Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Share by Country (2021-2032) Figure 61. Brazil Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 66. UAE Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 68. Chile Mammalian Biopharmaceutical Service Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Cell Line Development
  • Analytical Testing
  • Technology Transfer
  • Formulation Development
  • Others
Applications
  • Pharmaceutical
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Biotechnology Companies
  • Government Agencies
Companies covered
  • Novartis
  • KBI Biopharma
  • 3P Biopharmaceuticals
  • Sartorius Stedim Biotech
  • Merck Millipore
  • Rentschler Biopharma SE
  • Northway Biotech
  • Cambrex
  • Samsung Biologics
  • FUJIFILM Diosynth Biotechnologies
  • GBI
  • Thermo Fisher Scientific
  • Catalent
  • WuXi Biologics
  • Boehringer Ingelheim BioXcellence
  • Lonza
  • Abzena
  • AGC Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Mammalian Biopharmaceutical Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Cell Line Development
  5. 1.2.3 Analytical Testing
  6. 1.2.4 Technology Transfer
  7. 1.2.5 Formulation Development
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Mammalian Biopharmaceutical Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Pharmaceutical
  12. 1.3.3 Contract Research Organizations (CROs)
  13. 1.3.4 Academic and Research Institutes
  14. 1.3.5 Biotechnology Companies
  15. 1.3.6 Government Agencies
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Mammalian Biopharmaceutical Service Growth Trends by Region
  18. 1.5.1 Global Mammalian Biopharmaceutical Service Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Mammalian Biopharmaceutical Service Market Size by Region (2021-2026)
  20. 1.5.3 Mammalian Biopharmaceutical Service Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Mammalian Biopharmaceutical Service Market Dynamics
  1. 2.1 Mammalian Biopharmaceutical Service Industry Trends
  2. 2.2 Mammalian Biopharmaceutical Service Industry Drivers
  3. 2.3 Mammalian Biopharmaceutical Service Industry Opportunities and Challenges
  4. 2.4 Mammalian Biopharmaceutical Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Mammalian Biopharmaceutical Service Revenue by Company (2021-2026)
  2. 3.2 Global Mammalian Biopharmaceutical Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Mammalian Biopharmaceutical Service Key Company Head office and Area Served
  4. 3.4 Global Mammalian Biopharmaceutical Service Company, Product Type & Application
  5. 3.5 Global Mammalian Biopharmaceutical Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Mammalian Biopharmaceutical Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Mammalian Biopharmaceutical Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Mammalian Biopharmaceutical Service Tier 1, Tier 2, and Tier 3
4 Mammalian Biopharmaceutical Service Market by Type
  1. 4.1 Global Mammalian Biopharmaceutical Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Mammalian Biopharmaceutical Service Market Size by Type (2021-2032)
  3. 4.3 Global Mammalian Biopharmaceutical Service Market Size Share by Type (2021-2032)
5 Mammalian Biopharmaceutical Service Market by Application
  1. 5.1 Global Mammalian Biopharmaceutical Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Mammalian Biopharmaceutical Service Market Size by Application (2021-2032)
  3. 5.3 Global Mammalian Biopharmaceutical Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis Mammalian Biopharmaceutical Service Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 KBI Biopharma
  8. 6.2.1 KBI Biopharma Company Information
  9. 6.2.2 KBI Biopharma Business Overview
  10. 6.2.3 KBI Biopharma Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 KBI Biopharma Mammalian Biopharmaceutical Service Product Portfolio
  12. 6.2.5 KBI Biopharma Recent Developments
  13. 6.3 3P Biopharmaceuticals
  14. 6.3.1 3P Biopharmaceuticals Company Information
  15. 6.3.2 3P Biopharmaceuticals Business Overview
  16. 6.3.3 3P Biopharmaceuticals Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 3P Biopharmaceuticals Mammalian Biopharmaceutical Service Product Portfolio
  18. 6.3.5 3P Biopharmaceuticals Recent Developments
  19. 6.4 Sartorius Stedim Biotech
  20. 6.4.1 Sartorius Stedim Biotech Company Information
  21. 6.4.2 Sartorius Stedim Biotech Business Overview
  22. 6.4.3 Sartorius Stedim Biotech Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sartorius Stedim Biotech Mammalian Biopharmaceutical Service Product Portfolio
  24. 6.4.5 Sartorius Stedim Biotech Recent Developments
  25. 6.5 Merck Millipore
  26. 6.5.1 Merck Millipore Company Information
  27. 6.5.2 Merck Millipore Business Overview
  28. 6.5.3 Merck Millipore Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Merck Millipore Mammalian Biopharmaceutical Service Product Portfolio
  30. 6.5.5 Merck Millipore Recent Developments
  31. 6.6 Rentschler Biopharma SE
  32. 6.6.1 Rentschler Biopharma SE Company Information
  33. 6.6.2 Rentschler Biopharma SE Business Overview
  34. 6.6.3 Rentschler Biopharma SE Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Rentschler Biopharma SE Mammalian Biopharmaceutical Service Product Portfolio
  36. 6.6.5 Rentschler Biopharma SE Recent Developments
  37. 6.7 Northway Biotech
  38. 6.7.1 Northway Biotech Company Information
  39. 6.7.2 Northway Biotech Business Overview
  40. 6.7.3 Northway Biotech Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Northway Biotech Mammalian Biopharmaceutical Service Product Portfolio
  42. 6.7.5 Northway Biotech Recent Developments
  43. 6.8 Cambrex
  44. 6.8.1 Cambrex Company Information
  45. 6.8.2 Cambrex Business Overview
  46. 6.8.3 Cambrex Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Cambrex Mammalian Biopharmaceutical Service Product Portfolio
  48. 6.8.5 Cambrex Recent Developments
  49. 6.9 Samsung Biologics
  50. 6.9.1 Samsung Biologics Company Information
  51. 6.9.2 Samsung Biologics Business Overview
  52. 6.9.3 Samsung Biologics Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Samsung Biologics Mammalian Biopharmaceutical Service Product Portfolio
  54. 6.9.5 Samsung Biologics Recent Developments
  55. 6.10 FUJIFILM Diosynth Biotechnologies
  56. 6.10.1 FUJIFILM Diosynth Biotechnologies Company Information
  57. 6.10.2 FUJIFILM Diosynth Biotechnologies Business Overview
  58. 6.10.3 FUJIFILM Diosynth Biotechnologies Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 FUJIFILM Diosynth Biotechnologies Mammalian Biopharmaceutical Service Product Portfolio
  60. 6.10.5 FUJIFILM Diosynth Biotechnologies Recent Developments
  61. 6.11 GBI
  62. 6.11.1 GBI Company Information
  63. 6.11.2 GBI Business Overview
  64. 6.11.3 GBI Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 GBI Mammalian Biopharmaceutical Service Product Portfolio
  66. 6.11.5 GBI Recent Developments
  67. 6.12 Thermo Fisher Scientific
  68. 6.12.1 Thermo Fisher Scientific Company Information
  69. 6.12.2 Thermo Fisher Scientific Business Overview
  70. 6.12.3 Thermo Fisher Scientific Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Thermo Fisher Scientific Mammalian Biopharmaceutical Service Product Portfolio
  72. 6.12.5 Thermo Fisher Scientific Recent Developments
  73. 6.13 Catalent
  74. 6.13.1 Catalent Company Information
  75. 6.13.2 Catalent Business Overview
  76. 6.13.3 Catalent Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Catalent Mammalian Biopharmaceutical Service Product Portfolio
  78. 6.13.5 Catalent Recent Developments
  79. 6.14 WuXi Biologics
  80. 6.14.1 WuXi Biologics Company Information
  81. 6.14.2 WuXi Biologics Business Overview
  82. 6.14.3 WuXi Biologics Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 WuXi Biologics Mammalian Biopharmaceutical Service Product Portfolio
  84. 6.14.5 WuXi Biologics Recent Developments
  85. 6.15 Boehringer Ingelheim BioXcellence
  86. 6.15.1 Boehringer Ingelheim BioXcellence Company Information
  87. 6.15.2 Boehringer Ingelheim BioXcellence Business Overview
  88. 6.15.3 Boehringer Ingelheim BioXcellence Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Boehringer Ingelheim BioXcellence Mammalian Biopharmaceutical Service Product Portfolio
  90. 6.15.5 Boehringer Ingelheim BioXcellence Recent Developments
  91. 6.16 Lonza
  92. 6.16.1 Lonza Company Information
  93. 6.16.2 Lonza Business Overview
  94. 6.16.3 Lonza Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Lonza Mammalian Biopharmaceutical Service Product Portfolio
  96. 6.16.5 Lonza Recent Developments
  97. 6.17 Abzena
  98. 6.17.1 Abzena Company Information
  99. 6.17.2 Abzena Business Overview
  100. 6.17.3 Abzena Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Abzena Mammalian Biopharmaceutical Service Product Portfolio
  102. 6.17.5 Abzena Recent Developments
  103. 6.18 AGC Biologics
  104. 6.18.1 AGC Biologics Company Information
  105. 6.18.2 AGC Biologics Business Overview
  106. 6.18.3 AGC Biologics Mammalian Biopharmaceutical Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 AGC Biologics Mammalian Biopharmaceutical Service Product Portfolio
  108. 6.18.5 AGC Biologics Recent Developments
7 North America
  1. 7.1 North America Mammalian Biopharmaceutical Service Market Size (2021-2032)
  2. 7.2 North America Mammalian Biopharmaceutical Service Market Size by Type
  3. 7.2.1 North America Mammalian Biopharmaceutical Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Mammalian Biopharmaceutical Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Mammalian Biopharmaceutical Service Market Share by Type (2021-2032)
  6. 7.3 North America Mammalian Biopharmaceutical Service Market Size by Application
  7. 7.3.1 North America Mammalian Biopharmaceutical Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Mammalian Biopharmaceutical Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Mammalian Biopharmaceutical Service Market Share by Application (2021-2032)
  10. 7.4 North America Mammalian Biopharmaceutical Service Market Size by Country
  11. 7.4.1 North America Mammalian Biopharmaceutical Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Mammalian Biopharmaceutical Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Mammalian Biopharmaceutical Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Mammalian Biopharmaceutical Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Mammalian Biopharmaceutical Service Market Size (2021-2032)
  2. 8.2 Europe Mammalian Biopharmaceutical Service Market Size by Type
  3. 8.2.1 Europe Mammalian Biopharmaceutical Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Mammalian Biopharmaceutical Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Mammalian Biopharmaceutical Service Market Share by Type (2021-2032)
  6. 8.3 Europe Mammalian Biopharmaceutical Service Market Size by Application
  7. 8.3.1 Europe Mammalian Biopharmaceutical Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Mammalian Biopharmaceutical Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Mammalian Biopharmaceutical Service Market Share by Application (2021-2032)
  10. 8.4 Europe Mammalian Biopharmaceutical Service Market Size by Country
  11. 8.4.1 Europe Mammalian Biopharmaceutical Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Mammalian Biopharmaceutical Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Mammalian Biopharmaceutical Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Mammalian Biopharmaceutical Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Mammalian Biopharmaceutical Service Market Size (2021-2032)
  2. 9.2 China Mammalian Biopharmaceutical Service Market Size by Type
  3. 9.2.1 China Mammalian Biopharmaceutical Service Market Size by Type (2021-2026)
  4. 9.2.2 China Mammalian Biopharmaceutical Service Market Size by Type (2027-2032)
  5. 9.2.3 China Mammalian Biopharmaceutical Service Market Share by Type (2021-2032)
  6. 9.3 China Mammalian Biopharmaceutical Service Market Size by Application
  7. 9.3.1 China Mammalian Biopharmaceutical Service Market Size by Application (2021-2026)
  8. 9.3.2 China Mammalian Biopharmaceutical Service Market Size by Application (2027-2032)
  9. 9.3.3 China Mammalian Biopharmaceutical Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Mammalian Biopharmaceutical Service Market Size (2021-2032)
  2. 10.2 Asia Mammalian Biopharmaceutical Service Market Size by Type
  3. 10.2.1 Asia Mammalian Biopharmaceutical Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Mammalian Biopharmaceutical Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Mammalian Biopharmaceutical Service Market Share by Type (2021-2032)
  6. 10.3 Asia Mammalian Biopharmaceutical Service Market Size by Application
  7. 10.3.1 Asia Mammalian Biopharmaceutical Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Mammalian Biopharmaceutical Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Mammalian Biopharmaceutical Service Market Share by Application (2021-2032)
  10. 10.4 Asia Mammalian Biopharmaceutical Service Market Size by Country
  11. 10.4.1 Asia Mammalian Biopharmaceutical Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Mammalian Biopharmaceutical Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Mammalian Biopharmaceutical Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Mammalian Biopharmaceutical Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Mammalian Biopharmaceutical Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst